CTNNB1 and hepatoblastoma: Mutations in this region of CTNNB1 were identified in samples from HB3, HB5, HB7 and HB9 in our cohort (Figure 3), consistent with previous reports of such mutations being present in 60–90% of hepatoblastoma tumors [4,6].